- ASSISTANT PROFESSOR | Surgery
- Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Brooklyn
- The Mount Sinai Hospital
- Mount Sinai Queens
- Mount Sinai St. Luke's and Mount Sinai West
- Mount Sinai Doctors 718-808-7777718-808-7777
Dr. Sur is skilled in both open and laparoscopic approaches in oncologic surgery and strongly values an evidence-based, multidisciplinary approach to cancer care. She feels privileged to have an immediate impact on her patients through surgery, while also cultivating long lasting relationships through her care. She is also interested in the role of medical ethics in surgical oncology as it relates to communication between surgeons and patients and among physicians, and how improvements in these areas might enhance patient outcomes. She has authored several publications and given presentations in both surgical oncology and ethics. She is a member of the Society for Surgical Oncology, the Americas Hepato-Pancreato-Biliary Association, and the American College of Surgeons.
American Board of Surgery
- Abdominal Desmoid Tumor
- Breast Cancer
- Colorectal Cancer
- Colorectal Resection
- Gallbladder Cancer
- Laparoscopic Intestinal Surgery
- Liver Cancer
- Pancreatic Cancer
- Sentinel Lymph Node Biopsy
- Soft Tissue Sarcoma
- Stomach Cancer
- Thyroid Cancer
AB, Harvard College
MD, Mount Sinai School of Medicine
Internship, General Surgery
Mount Sinai School of Medicine
Residency, General Surgery
The Mount Sinai Hospital
Fellowship, Surgery Oncology
University of Chicago Hospitals
Arthur H. Aufses, Sr. Prize in Surgery
Mount Sinai Hospital
Medical Student Teaching Award
Mount Sinai Hospital
Eugene W. Friedman, MD, Prize for Clinical Excellence
David McCord Prize for the Arts
Harvard College Scholarship for Academic Achievement
Sur MD, In H, Sharpe SM, Baker MS, Weichselbaum RR, Talamonti MS, Posner MC. Defining the Benefit of Adjuvant Therapy Following Resection for Intrahepatic Cholangiocarcinoma. Annals of surgical oncology 2015 Jul; 22(7).
Sur MD, Namm JP, Hemmerich JA, Buschmann MM, Roggin KK, Dale W. Radiographic Sarcopenia and Self-reported Exhaustion Independently Predict NSQIP Serious Complications After Pancreaticoduodenectomy in Older Adults. Annals of surgical oncology 2015 Nov; 22(12).
Sur MD, Schindler N, Singh P, Angelos P, Langerman A. Young surgeons on speaking up: when and how surgical trainees voice concerns about supervisors' clinical decisions. American journal of surgery 2016 Feb; 211(2).
Sur MD, Angelos P. Ethical Issues in Surgical Critical Care: The Complexity of Interpersonal Relationships in the Surgical Intensive Care Unit. Journal of intensive care medicine 2016 Aug; 31(7).
Sur MD, Romanoff AM, Greenstein AJ, Greenstein AJ. Laparoscopic ileocolic resection for perforated Crohn's disease in pregnancy. Journal of Crohn's & colitis 2013 Sep; 7(8).
Butala P, Greenstein AJ, Sur MD, Mehta N, Sadot E, Divino CM. Surgical management of acute right lower-quadrant pain in pregnancy: a prospective cohort study. Journal of the American College of Surgeons 2010 Oct; 211(4).
Telem DA, Sur M, Tabrizian P, Chao TE, Nguyen SQ, Chin EH, Divino CM. Diagnosis of gastrointestinal anastomotic dehiscence after hospital discharge: Impact on patient management and outcome. Surgery 2010 Jan; 147(1).
Sur MD, Nguyen SQ, Labow DM, Scordi-Bello I, Lento PA, Hyun JG. Pseudoxanthoma elasticum: a case of total gastrectomy for gastric hemorrhage. The American surgeon 2008 Apr; 74(4).
Sur MD, Choi EA. When should patients with liver metastases from colorectal cancer receive chemotherapy?. In: Difficult Decisions in Hepatobiliary and Pancreatic Surgery – An Evidence-Based Approach. New York, Springer;.
Sur MD, Divino CM. Non-acute abdominal conditions. In: Hamilton-Bailey’s Demonstrations of Physical Signs in Clinical Surgery. 19th edition.
Sur MD, Weber K. Hypercalcemia. In: Common Surgical Diseases: An Algorithmic Approach. 3rd edition. New York, Springer;.
Sur MD, Katz LB. Evolution of Ventral and Incisional Hernia Repair. In: SAGES Manual of Hernia Repair. New York, Springer;.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Sur did not report having any of the following types of financial relationships with industry during 2017 and/or 2018: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.